Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
150%(6 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_2
3
38%
Ph phase_3
3
38%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Terminated2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (37.5%)
Phase 33 (37.5%)
Phase 42 (25.0%)

Trials by Status

withdrawn113%
completed450%
unknown113%
terminated225%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_2

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

NCT04511026
completedphase_2

Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer

NCT03405142
completedphase_4

Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer

NCT02287675
unknownphase_4

Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer

NCT04261179
withdrawnphase_2

A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

NCT02857608
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04511026Phase 2

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Terminated
NCT03405142Phase 2

Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer

Completed
NCT02287675Phase 4

Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer

Completed
NCT04261179Phase 4

Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer

Unknown
NCT02857608Phase 2

A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

Withdrawn
NCT00911326Phase 3

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

Terminated
NCT00671918Phase 3

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Completed
NCT01106040Phase 3

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8